Okanoue T - Search Results

1

Current and new pharmacotherapy options for non-alcoholic steatohepatitis.

Sumida Y, Yoneda M, Ogawa Y, Yoneda M, Okanoue T, Nakajima A. Sumida Y, et al. Among authors: okanoue t. Expert Opin Pharmacother. 2020 Jun;21(8):953-967. doi: 10.1080/14656566.2020.1744564. Epub 2020 Apr 1. Expert Opin Pharmacother. 2020. PMID: 32237916 Review.

2

Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants.

Mitsuyoshi H, Nakashima T, Sumida Y, Yoh T, Nakajima Y, Ishikawa H, Inaba K, Sakamoto Y, Okanoue T, Kashima K. Mitsuyoshi H, et al. Among authors: okanoue t. Biochem Biophys Res Commun. 1999 Sep 24;263(2):537-42. doi: 10.1006/bbrc.1999.1403. Biochem Biophys Res Commun. 1999. PMID: 10491327

3

Effects of glycyrrhizin on glucocorticoid signaling pathway in hepatocytes.

Yoh T, Nakashima T, Sumida Y, Kakisaka Y, Nakajima Y, Ishikawa H, Sakamoto Y, Okanoue T, Mitsuyoshi H. Yoh T, et al. Among authors: okanoue t. Dig Dis Sci. 2002 Aug;47(8):1775-81. doi: 10.1023/a:1016492527927. Dig Dis Sci. 2002. PMID: 12184529

4

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease.

Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y, Nakajima Y, Ishikawa H, Mitsuyoshi H, Okanoue T, Kashima K, Nakamura H, Yodoi J. Sumida Y, et al. Among authors: okanoue t. J Hepatol. 2003 Jan;38(1):32-8. doi: 10.1016/s0168-8278(02)00331-8. J Hepatol. 2003. PMID: 12480557

5

Insulin resistance/beta-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection.

Furutani M, Nakashima T, Sumida Y, Hirohama A, Yoh T, Kakisaka Y, Mitsuyoshi H, Senmaru H, Okanoue T. Furutani M, et al. Among authors: okanoue t. Liver Int. 2003 Aug;23(4):294-9. doi: 10.1034/j.1600-0676.2003.00841.x. Liver Int. 2003. PMID: 12895270

6

[A case of liver cirrhosis B resistant to lamivudine showing the clinical effect of adefovir dipivoxil].

Sumida Y, Kanemasa K, Tachibana S, Maekawa K, Mori K, Minami M, Okanoue T. Sumida Y, et al. Among authors: okanoue t. Nihon Shokakibyo Gakkai Zasshi. 2004 May;101(5):521-4. Nihon Shokakibyo Gakkai Zasshi. 2004. PMID: 15168763 Japanese. No abstract available.

7

[Influence of Helicobacter pylori infection on iron accumulation in hepatitis C].

Sumida Y, Kanemasa K, Tachibana T, Maekawa K, Nakajima T, Mitsuyoshi H, Ito Y, Okanoue T. Sumida Y, et al. Among authors: okanoue t. Nihon Shokakibyo Gakkai Zasshi. 2004 Sep;101(9):1010. Nihon Shokakibyo Gakkai Zasshi. 2004. PMID: 15478666 Japanese. No abstract available.

8

[Treatment of nonalcoholic steatohepatitis (NASH)].

Nakashima T, Sumida Y, Mitsuyoshi H, Okanoue T. Nakashima T, et al. Among authors: okanoue t. Nihon Shokakibyo Gakkai Zasshi. 2004 Nov;101(11):1204-8. Nihon Shokakibyo Gakkai Zasshi. 2004. PMID: 15570868 Review. Japanese. No abstract available.

9

A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.

Okanoue T, Makiyama A, Nakayama M, Sumida Y, Mitsuyoshi H, Nakajima T, Yasui K, Minami M, Itoh Y. Okanoue T, et al. J Hepatol. 2005 Oct;43(4):599-605. doi: 10.1016/j.jhep.2005.04.008. J Hepatol. 2005. PMID: 16024129

10

Natural course of asymptomatic hepatitis C virus-infected patients and hepatocellular carcinoma after interferon therapy.

Okanoue T, Minami M, Makiyama A, Sumida Y, Yasui K, Itoh Y. Okanoue T, et al. Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S89-91. doi: 10.1016/s1542-3565(05)00701-9. Clin Gastroenterol Hepatol. 2005. PMID: 16234069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

467 results

Search Page